Skip to content
NeuroTechGuide

StairMed begins formal preparation for a China A-share listing

The Shanghai implant maker has registered for pre-listing tutoring with Huatai United Securities, which is an early step and not yet a listing application.

In briefImplantsIndustry

StairMed has registered for pre-listing tutoring with the Shanghai bureau of China’s securities regulator, Chinese media reported on November 3, citing a filing dated November 2. Tutoring is the preparation Chinese companies complete before applying for an A-share listing, and Huatai United Securities is the adviser. The Paper reports that the company has raised RMB 2.6 billion in total, about RMB 1.4 billion of it in the second half of 2026.

This is an early step: reports name no exchange, timetable or fundraising target. StairMed would join other Chinese BCI companies preparing to list, including Neuracle, whose STAR Market application is under review. The company says it has completed 42 long-term implants.

Learn more: StairMed in the Directory

Share:XLinkedInBlueskyEmail

More news